1st Circuit Affirms Dismissal Of Actos Prediabetes Off-Label False Claims Lawsuit

(November 28, 2016, 2:09 PM EST) -- BOSTON — The First Circuit U.S. Court of Appeals on Nov. 22 affirmed dismissal of an Actos off-label whistle-blower lawsuit, agreeing with a lower court judge that the relator failed to plead that the alleged actions resulted in false claims being filed with state Medicare programs (Peter W. Lawton, ex rel. United States of America v. Takeda Pharmaceutical Company, Ltd., et al., No. 16-1382, 1st Cir.; 2016 U.S. App. LEXIS 20943)....

Attached Documents

Related Sections